Elizabeth Trachtenberg Selected Research

Graft vs Host Disease (Graft-Versus-Host Disease)

11/2013	Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.
10/2004	Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth Trachtenberg Research Topics

Disease

5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 01/2009
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2012
2	Leukemia 05/2014 - 03/2009
2	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2013 - 10/2004
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016
1	Otitis 10/2012
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2012
1	Disease Susceptibility (Diathesis) 06/2012
1	Infections 03/2009

Drug/Important Bio-Agent (IBA)

4	KIR ReceptorsIBA 01/2022 - 11/2013
3	Peptides (Polypeptides)IBA 11/2013 - 03/2009
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2019
2	HLA-A Antigens (HLA-A)IBA 11/2013 - 10/2004
1	EnzymesIBA 01/2022
1	ArginaseIBA 01/2022
1	CytokinesIBA 01/2022
1	LigandsIBA 05/2014
1	HLA-C Antigens (HLA-C)IBA 05/2014
1	HLA-DPB1 antigen (HLA DPB1)IBA 10/2012
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2012
1	HLA-DP Antigens (HLA-DP)IBA 10/2012
1	Natural Killer Cell ReceptorsIBA 10/2010
1	AntigensIBA 03/2009
1	Proteins (Proteins, Gene)FDA Link 03/2009

Therapy/Procedure

3	Transplantation 01/2016 - 10/2010
2	Cell Transplantation 05/2014 - 01/2009
2	Donor Selection 05/2014 - 10/2010